SBC Medical Group Holdings Incorporated (NASDAQ:SBC) Sees Large Growth in Short Interest

SBC Medical Group Holdings Incorporated (NASDAQ:SBC) was the recipient of a significant growth in short interest during the month of December. As of December 31st, there was short interest totaling 401,307 shares, a growth of 179.2% from the December 15th total of 143,744 shares. Based on an average trading volume of 106,270 shares, the short-interest ratio is currently 3.8 days. Approximately 3.7% of the company’s shares are short sold. Approximately 3.7% of the company’s shares are short sold. Based on an average trading volume of 106,270 shares, the short-interest ratio is currently 3.8 days.

SBC Medical Group Trading Down 0.2%

Shares of NASDAQ SBC opened at $4.46 on Wednesday. The company has a current ratio of 5.10, a quick ratio of 5.06 and a debt-to-equity ratio of 0.07. The stock has a market capitalization of $457.51 million, a PE ratio of 10.88 and a beta of 1.14. SBC Medical Group has a twelve month low of $2.62 and a twelve month high of $7.00. The stock has a fifty day simple moving average of $3.88 and a 200-day simple moving average of $4.18.

SBC Medical Group (NASDAQ:SBC) last announced its earnings results on Friday, November 14th. The company reported $0.12 EPS for the quarter, missing analysts’ consensus estimates of $0.13 by ($0.01). The firm had revenue of $43.35 million for the quarter, compared to analysts’ expectations of $46.45 million. SBC Medical Group had a net margin of 24.28% and a return on equity of 24.17%. On average, equities analysts forecast that SBC Medical Group will post 5.02 earnings per share for the current year.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the business. XTX Topco Ltd acquired a new stake in SBC Medical Group during the 2nd quarter worth approximately $64,000. New York State Common Retirement Fund acquired a new stake in shares of SBC Medical Group in the second quarter valued at $104,000. SBI Securities Co. Ltd. boosted its holdings in SBC Medical Group by 227.3% in the second quarter. SBI Securities Co. Ltd. now owns 54,177 shares of the company’s stock valued at $251,000 after purchasing an additional 37,623 shares during the period. Millennium Management LLC purchased a new stake in SBC Medical Group during the 3rd quarter worth about $219,000. Finally, Geode Capital Management LLC acquired a new stake in SBC Medical Group in the 2nd quarter valued at about $455,000. Institutional investors and hedge funds own 60.82% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have issued reports on SBC shares. Wall Street Zen raised SBC Medical Group from a “hold” rating to a “buy” rating in a research note on Saturday, September 20th. Weiss Ratings reissued a “sell (d+)” rating on shares of SBC Medical Group in a research report on Monday, December 29th. Finally, Maxim Group initiated coverage on shares of SBC Medical Group in a research report on Wednesday, November 5th. They issued a “buy” rating and a $9.00 target price on the stock. One analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $9.00.

About SBC Medical Group

SBC Medical Group, Inc is a publicly traded healthcare management services company listed on the Nasdaq under the ticker SBC. The company specializes in supporting in-office ancillary service providers by offering a suite of administrative and operational solutions designed to streamline practice management and enhance revenue performance. Its core mission is to help physician practices, imaging centers and other ancillary service providers focus on patient care while outsourcing complex back-office functions.

The company’s primary offerings include revenue cycle management, medical billing and coding, compliance oversight and transcription services.